Legend Biotech Corporation (LEGN)

Trade LEGN now with
7/26/2022 8:23:26 PM Legend Biotech Prices Public Offering Of 8.14 Mln ADSs At $43.00/ADS For Total Gross Proceeds Of About $350 Mln
5/9/2022 6:47:01 AM Legend Biotech Appoints Lori Macomber As CFO
3/25/2022 8:12:05 AM LEGN : CARVYKTI Receives Positive CHMP Opinion For Treatment Of Patients With Relapsed And Refractory Multiple Myeloma
3/18/2022 4:12:32 PM Legend Biotech Q4 Loss/share $0.30 Vs. Loss $0.22 Year Ago
2/15/2022 8:34:29 AM Legend Biotech Announces FDA Clinical Hold Of Phase 1 Clinical Trial For LB1901; Stock Drops
12/16/2021 9:25:40 AM Legend Biotech Prices Public Offering Of 7.50 Mln At $40.00/ADS
6/22/2021 8:12:17 AM Legend Biotech Announces Establishment Of State-of-the-art Manufacturing Facility In Belgium
4/30/2021 7:20:23 AM Legend Biotech Submits EMA For Ciltacabtagene Autoleucel For Relapsed And/or Refractory Multiple Myeloma
2/1/2021 7:21:30 AM Legend Biotech Says BCMA CAR-T Therapy Cilta-cel Accepted For Accelerated Assessment In Europe